High-Grade Serous Ovarian Carcinoma Organoids As Models of Chromosomal Instability

To develop clinically relevant models of these mutational processes investigators derived 15 continuous high-grade serous ovarian carcinoma patient-derived organoids and characterized them using bulk transcriptomic, bulk genomic, single-cell genomic, and drug sensitivity assays.